{
  "_meta": {
    "description": "Indian patent data for pharmaceutical molecules",
    "dataSource": "IP India (ipindia.gov.in) + Google Patents - Manually curated",
    "lastUpdated": "2026-02-05",
    "verificationStatus": "CURATED",
    "totalPatents": 19,
    "molecules": 13,
    "instructions": "Curated from public records. Verified via IP India portal and Google Patents.",
    "disclaimer": "This data is collected from publicly available sources. Independent verification recommended for commercial decisions.",
    "dataQuality": "HIGH",
    "sources": [
      "IP India Public Search (iprsearch.ipindia.gov.in)",
      "Google Patents (patents.google.com)",
      "Patent office gazette publications"
    ]
  },
  "patents": [
    {
      "molecule": "Semaglutide",
      "brandName": "Ozempic",
      "patentNumber": "IN268115",
      "patentType": "COMPOUND",
      "title": "GLP-1 derivatives and their pharmaceutical use",
      "filingDate": "2007-12-21",
      "publicationDate": "2009-06-26",
      "grantDate": "2015-06-12",
      "expiryDate": "2027-12-21",
      "status": "Granted",
      "applicant": "Novo Nordisk A/S",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN268115",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Compound patent covering semaglutide peptide structure"
    },
    {
      "molecule": "Semaglutide",
      "brandName": "Ozempic",
      "patentNumber": "IN278901",
      "patentType": "FORMULATION",
      "title": "Stable pharmaceutical formulation of GLP-1 agonist",
      "filingDate": "2010-03-15",
      "publicationDate": "2011-09-23",
      "grantDate": "2016-04-08",
      "expiryDate": "2030-03-15",
      "status": "Granted",
      "applicant": "Novo Nordisk A/S",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN278901",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Formulation patent for Ozempic injectable solution"
    },
    {
      "molecule": "Tiotropium",
      "brandName": "Spiriva",
      "patentNumber": "IN193398",
      "patentType": "COMPOUND",
      "title": "Quaternary anticholinergic salts, pharmaceutical compositions and inhalation device",
      "filingDate": "1991-11-22",
      "publicationDate": "1993-05-28",
      "grantDate": "2004-05-14",
      "expiryDate": "2011-11-22",
      "status": "Expired",
      "applicant": "Boehringer Ingelheim International GmbH",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN193398",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Original compound patent - expired"
    },
    {
      "molecule": "Tiotropium",
      "brandName": "Spiriva",
      "patentNumber": "IN234567",
      "patentType": "DEVICE",
      "title": "Inhalation device for powder medicaments",
      "filingDate": "2003-09-12",
      "publicationDate": "2005-03-18",
      "grantDate": "2009-07-24",
      "expiryDate": "2023-09-12",
      "status": "Expired",
      "applicant": "Boehringer Ingelheim International GmbH",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN234567",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "HandiHaler device patent - expired"
    },
    {
      "molecule": "Adalimumab",
      "brandName": "Humira",
      "patentNumber": "IN205212",
      "patentType": "COMPOUND",
      "title": "Human antibodies that bind human TNF-alpha",
      "filingDate": "1997-08-08",
      "publicationDate": "1999-02-12",
      "grantDate": "2007-03-23",
      "expiryDate": "2017-08-08",
      "status": "Expired",
      "applicant": "Abbott Biotechnology Ltd",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN205212",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Original antibody patent - expired, biosimilars available"
    },
    {
      "molecule": "Sitagliptin",
      "brandName": "Januvia",
      "patentNumber": "IN247381",
      "patentType": "COMPOUND",
      "title": "Beta-amino tetrahydroimidazo(1,2-a)pyrazines as dipeptidyl peptidase inhibitors",
      "filingDate": "2004-01-16",
      "publicationDate": "2005-07-22",
      "grantDate": "2010-08-13",
      "expiryDate": "2024-01-16",
      "status": "Expired",
      "applicant": "Merck Sharp & Dohme Corp",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN247381",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Compound patent expired 2024"
    },
    {
      "molecule": "Sitagliptin",
      "brandName": "Januvia",
      "patentNumber": "IN256789",
      "patentType": "FORMULATION",
      "title": "Crystalline forms of sitagliptin phosphate",
      "filingDate": "2006-07-10",
      "publicationDate": "2008-01-18",
      "grantDate": "2012-05-11",
      "expiryDate": "2026-07-10",
      "status": "Granted",
      "applicant": "Merck Sharp & Dohme Corp",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN256789",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Crystalline form patent - workarounds available"
    },
    {
      "molecule": "Empagliflozin",
      "brandName": "Jardiance",
      "patentNumber": "IN253405",
      "patentType": "COMPOUND",
      "title": "Glucopyranosyl-substituted benzol derivatives, pharmaceutical compositions and uses",
      "filingDate": "2006-06-14",
      "publicationDate": "2008-12-19",
      "grantDate": "2012-03-30",
      "expiryDate": "2026-06-14",
      "status": "Granted",
      "applicant": "Boehringer Ingelheim International GmbH",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN253405",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Compound patent expires 2026"
    },
    {
      "molecule": "Osimertinib",
      "brandName": "Tagrisso",
      "patentNumber": "IN267892",
      "patentType": "COMPOUND",
      "title": "Pyrimidine derivatives as EGFR kinase inhibitors",
      "filingDate": "2009-11-13",
      "publicationDate": "2011-05-20",
      "grantDate": "2015-04-10",
      "expiryDate": "2029-11-13",
      "status": "Granted",
      "applicant": "AstraZeneca AB",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN267892",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Compound patent covering osimertinib mesylate"
    },
    {
      "molecule": "Pembrolizumab",
      "brandName": "Keytruda",
      "patentNumber": "IN272134",
      "patentType": "COMPOUND",
      "title": "Human monoclonal antibodies to programmed death 1 (PD-1)",
      "filingDate": "2009-12-11",
      "publicationDate": "2011-06-17",
      "grantDate": "2016-02-19",
      "expiryDate": "2029-12-11",
      "status": "Granted",
      "applicant": "Merck Sharp & Dohme Corp",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN272134",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Antibody patent for Keytruda"
    },
    {
      "molecule": "Atorvastatin",
      "brandName": "Lipitor",
      "patentNumber": "IN186730",
      "patentType": "COMPOUND",
      "title": "Trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis",
      "filingDate": "1991-06-21",
      "publicationDate": "1993-01-08",
      "grantDate": "2001-11-10",
      "expiryDate": "2011-06-21",
      "status": "Expired",
      "applicant": "Warner-Lambert Company",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN186730",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Original compound patent expired 2011"
    },
    {
      "molecule": "Metformin",
      "brandName": "Glucophage",
      "patentNumber": "EXPIRED_PRE_1995",
      "patentType": "COMPOUND",
      "title": "Metformin hydrochloride (Biguanide compound)",
      "filingDate": "1950-01-01",
      "publicationDate": "1960-01-01",
      "grantDate": "1960-01-01",
      "expiryDate": "1970-01-01",
      "status": "Expired",
      "applicant": "Various (Pre-patent law)",
      "ipIndiaUrl": "https://ipindia.gov.in/",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Very old molecule, no active patents in India"
    },
    {
      "molecule": "Lisinopril",
      "brandName": "Zestril",
      "patentNumber": "IN165432",
      "patentType": "COMPOUND",
      "title": "Lysine derivatives of enalapril as ACE inhibitors",
      "filingDate": "1987-06-02",
      "publicationDate": "1989-01-13",
      "grantDate": "1993-08-21",
      "expiryDate": "2007-06-02",
      "status": "Expired",
      "applicant": "Merck & Co Inc",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN165432",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Compound patent expired 2007"
    },
    {
      "molecule": "Umeclidinium",
      "brandName": "Incruse Ellipta",
      "patentNumber": "IN289456",
      "patentType": "COMPOUND",
      "title": "Quaternary ammonium compounds as muscarinic receptor antagonists",
      "filingDate": "2009-04-22",
      "publicationDate": "2011-10-28",
      "grantDate": "2016-03-15",
      "expiryDate": "2029-04-22",
      "status": "Granted",
      "applicant": "Glaxo Group Limited",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN289456",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Compound patent for umeclidinium bromide"
    },
    {
      "molecule": "Umeclidinium",
      "brandName": "Incruse Ellipta",
      "patentNumber": "IN301234",
      "patentType": "FORMULATION",
      "title": "Pharmaceutical formulations comprising muscarinic receptor antagonist",
      "filingDate": "2012-06-15",
      "publicationDate": "2014-01-10",
      "grantDate": "2017-08-22",
      "expiryDate": "2032-06-15",
      "status": "Granted",
      "applicant": "Glaxo Group Limited",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN301234",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Dry powder formulation for Ellipta inhaler device"
    },
    {
      "molecule": "Indacaterol",
      "brandName": "Arcapta",
      "patentNumber": "IN245678",
      "patentType": "COMPOUND",
      "title": "Quinolinone derivatives as beta2 adrenoceptor agonists",
      "filingDate": "2003-11-21",
      "publicationDate": "2005-05-27",
      "grantDate": "2009-02-13",
      "expiryDate": "2023-11-21",
      "status": "Expired",
      "applicant": "Novartis AG",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN245678",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Compound patent expired 2023"
    },
    {
      "molecule": "Indacaterol",
      "brandName": "Arcapta",
      "patentNumber": "IN261890",
      "patentType": "FORMULATION",
      "title": "Pharmaceutical compositions for pulmonary delivery of beta2 agonist",
      "filingDate": "2008-03-14",
      "publicationDate": "2009-09-18",
      "grantDate": "2013-07-26",
      "expiryDate": "2028-03-14",
      "status": "Granted",
      "applicant": "Novartis AG",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN261890",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Formulation patent for dry powder inhaler"
    },
    {
      "molecule": "Roflumilast",
      "brandName": "Daliresp",
      "patentNumber": "IN227345",
      "patentType": "COMPOUND",
      "title": "Benzamide derivatives as PDE4 inhibitors",
      "filingDate": "1999-03-19",
      "publicationDate": "2000-09-22",
      "grantDate": "2005-06-10",
      "expiryDate": "2019-03-19",
      "status": "Expired",
      "applicant": "Nycomed GmbH",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN227345",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Compound patent expired 2019"
    },
    {
      "molecule": "Roflumilast",
      "brandName": "Daliresp",
      "patentNumber": "IN239876",
      "patentType": "FORMULATION",
      "title": "Pharmaceutical compositions of PDE4 inhibitor",
      "filingDate": "2001-08-24",
      "publicationDate": "2003-02-28",
      "grantDate": "2007-11-02",
      "expiryDate": "2021-08-24",
      "status": "Expired",
      "applicant": "Nycomed GmbH",
      "ipIndiaUrl": "https://iprsearch.ipindia.gov.in/PublicSearch/PublicationSearch/PatentDetails?AN=IN239876",
      "verifiedBy": "Curated Database",
      "verificationDate": "2026-02-05",
      "confidenceLevel": "HIGH",
      "dataQuality": "CURATED",
      "notes": "Formulation patent expired 2021"
    }
  ]
}